布加替尼-话题@MedSci

#布加替尼#

4篇内容 | 628人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1986783, encodeId=e2081986e83b6, content=<a href='/topic/show?id=7e444839ec7' target=_blank style='color:#2F92EE;'>#布加替尼#</a>, objectTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, objectType=article, longId=217316, objectId=e44421e31653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e44421e31653, replyNumber=0, likeNumber=48, createdTime=2021-12-25, rootId=0, userName=陈吴1234, userId=cbf451, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e44421e31653, moduleTitle=J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e44421e31653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986782, encodeId=c2f41986e82e5, content=<a href='/topic/show?id=7e444839ec7' target=_blank style='color:#2F92EE;'>#布加替尼#</a>, objectTitle=Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究, objectType=article, longId=213524, objectId=54582135246b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54582135246b, replyNumber=0, likeNumber=45, createdTime=2022-03-14, rootId=0, userName=陈吴1234, userId=cbf451, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54582135246b, moduleTitle=Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54582135246b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986781, encodeId=b3061986e8132, content=<a href='/topic/show?id=7e444839ec7' target=_blank style='color:#2F92EE;'>#布加替尼#</a>, objectTitle=布加替尼一线治疗ALK突变NSCLC研究进展及其在中国人群中的应用前景, objectType=article, longId=168246, objectId=21b816824610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21b816824610, replyNumber=0, likeNumber=39, createdTime=2019-09-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21b816824610, moduleTitle=布加替尼一线治疗ALK突变NSCLC研究进展及其在中国人群中的应用前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21b816824610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1986780, encodeId=2a3c1986e8045, content=<a href='/topic/show?id=7e444839ec7' target=_blank style='color:#2F92EE;'>#布加替尼#</a>, objectTitle=NICE推荐布加替尼Alunbrig用于治疗非小细胞肺癌, objectType=article, longId=160400, objectId=625016040034, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625016040034, replyNumber=0, likeNumber=40, createdTime=2019-10-07, rootId=0, userName=陈吴1234, userId=cbf451, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625016040034, moduleTitle=NICE推荐布加替尼Alunbrig用于治疗非小细胞肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625016040034)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

布加替尼

2020-05-29

陈吴1234 (审核中...)

前往app查看评论内容

#布加替尼#

J Thorac Oncol：Brigatinib（布加替尼）vs Crizotinib（克唑替尼）治疗未治ALK阳性晚期非小细胞肺癌患者的疗效：3期临床研究ALTA-1L最终分析结果

2021-12-25

陈吴1234 (审核中...)

前往app查看评论内容

#布加替尼#

Lung Cancer：布加替尼（brigatinib）治疗既往治疗过的ALK+转移性非小细胞肺癌患者的疗效：真实世界研究

2022-03-14

仁者大医 (审核中...)

前往app查看评论内容

#布加替尼#

布加替尼一线治疗ALK突变NSCLC研究进展及其在中国人群中的应用前景

2019-09-25

陈吴1234 (审核中...)

前往app查看评论内容

#布加替尼#

NICE推荐布加替尼Alunbrig用于治疗非小细胞肺癌

2019-10-07

科室
- - 订阅+
  - 更多科室
工具
服务